Role of perfusion CT in assessing tumor blood flow and malignancy level of gastric cancer

Digestive Surgery

Volumn 27, Issue 4, 2010, Pages 253-260

  Satoh, Asami ^a   Shuto, Kiyohiko ^a   Okazumi, Shinichi ^a   Ohira, Gaku ^a   Natsume, Toshiyuki ^a   Hayano, Koichi ^a   Narushima, Kazuo ^a   Saito, Hiroshige ^a   Ohta, Takumi ^a   Nabeya, Yoshihiro ^a   Yanagawa, Noriyuki ^b   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiogenesis; Blood flow; Intratumoral hemodynamics; Perfusion computed tomography; Tumor stroma

Indexed keywords

ADULT; AGED; BLOOD FLOW; CANCER INVASION; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; PATHOLOGY; PERFUSION; RADIOGRAPHY; REVIEW; STOMACH TUMOR; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PERFUSION; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954930783     PISSN: 02534886     EISSN: 14219883     Source Type: Journal    
DOI: 10.1159/000288703     Document Type: Review

References (31)

1. Crawford J: The gastrointestinal tract; in Robbins S, Kumar V, Schoen F (eds): Pathologic Basis of Disease. Philadelphia, Saunders, 1994, pp 755-783.
2. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L: Subtotal versus total gastrectomy for gastric cancer: Five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999; 230: 170-178.
3. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993; 72: 2089-2097.
4. Siewert JR, Bottcher K, Stein HJ, Roder JD: Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461.
5. Folkman J: What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990; 82: 4-6.
6. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
7. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX, Rosenberg SA: A randomized trial of bevacizumab, an antivascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003; 349: 427-434.
8. Chung YS, Maeda K, Sowa M: Prognostic value of angiogenesis in gastrointestinal tumours. Eur J Cancer 1996; 32A:2501-2505.
9. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C: Vascular grading of angiogenesis: Prognostic significance in breast cancer. Br J Cancer 2000; 82: 339-347.
10. Matsuyama K, Chiba Y, Sasaki M, Tanaka H, Muraoka R, Tanigawa N: Tumor angiogenesis as a prognostic marker in operable nonsmall cell lung cancer. Ann Thorac Surg 1998; 65: 1405-1409.
11. Cuenod CA, Fournier L, Balvay D, Guinebretiere JM: Tumor angiogenesis: Pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006; 31: 188-193.
12. Lee TY, Purdie TG, Stewart E: CT imaging of angiogenesis. Q J Nucl Med 2003; 47: 171-187.
13. Swensen SJ, Viggiano RW, Midthun DE, Muller NL, Sherrick A, Yamashita K, Naidich DP, Patz EF, Hartman TE, Muhm JR, Weaver AL: Lung nodule enhancement at CT: Multicenter study. Radiology 2000; 214: 73-80.
14. Sobin LH, Fleming ID: TNM Classification of Malignant Tumors, ed 5 (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
15. Meier P, Zierler KL: On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954; 6: 731-744.
16. Kumano S, Murakami T, Kim T, Hori M, Iannaccone R, Nakata S, Onishi H, Osuga K, Tomoda K, Catalano C, Nakamura H: T staging of gastric cancer: Role of multi-detector row CT. Radiology 2005; 237: 961-966.
17. Kan Z, Phongkitkarun S, Kobayashi S, Tang Y, Ellis LM, Lee TY, Charnsangavej C: Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology 2005; 237: 151-158.
18. Dugdale PE, Miles KA, Bunce I, Kelley BB, Leggett DA: CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr 1999; 23: 540-547.
19. Haider MA, Milosevic M, Fyles A, Sitartchouk I, Yeung I, Henderson E, Lockwood G, Lee TY, Roberts TP: Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 2005; 62: 1100-1107.
20. Li ZP, Meng QF, Sun CH, Xu DS, Fan M, Yang XF, Chen DY: Tumor angiogenesis and dynamic CT in colorectal carcinoma: Radiologic-pathologic correlation. World J Gastroenterol 2005; 11: 1287-1291.
21. Chen CN, Cheng YM, Lin MT, Hsieh FJ, Lee PH, Chang KJ: Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann Surg 2002; 235: 512-518.
22. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S: Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 2000; 89: 1418-1424.
23. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
24. Jonasson L, Hallgrimsson J, Olafsdottir G: Gastric carcinoma: Correlation of diagnosis based on biopsies and resection specimens with reference to the Lauren classification. APMIS 1994;102:711-715.
25. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9-19.
26. Brown JM, Giaccia AJ: The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-1416.
27. Jain RK: Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 58-65.
28. Miles KA: Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review. Eur J Radiol 1999; 30: 198-205.
29. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH, et al: Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
30. Boucher Y, Leunig M, Jain RK: Tumor angiogenesis and interstitial hypertension. Cancer Res 1996; 56: 4264-4266.
31. Milosevic MF, Fyles AW, Hill RP: The relationship between elevated interstitial fluid pressure and blood flow in tumors: A bioengineering analysis. Int J Radiat Oncol Biol Phys 1999; 43: 1111-1123.